Lobeglitazone, a novel thiazolidinedione, for secondary prevention in patients with ischemic stroke: a nationwide nested case-control study

Abstract Introduction Ischemic stroke patients with diabetes are at high risk for recurrent stroke and cardiovascular complications. Pioglitazone, a type of thiazolidinedione, has been shown to reduce cardiovascular complications in patients with ischemic stroke and type 2 diabetes (T2D) or insulin...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Joonsang Yoo, Jimin Jeon, Minyoul Baik, Jinkwon Kim
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	BMC 2023-05-01
Seri Bilgileri:	Cardiovascular Diabetology
Konular:	Type 2 Diabetes Mellitus Cardiovascular Disease Cohort Study Thiazolidinedione Lobeglitazone
Online Erişim:	https://doi.org/10.1186/s12933-023-01841-4
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!